Core Insights - Southbound funds reduced their holdings in HeartCare Medical-B (02160.HK) by 77,000 shares on September 18, 2025, marking a continuous trend of selling over the past trading days [1] - Over the last 5 trading days, there has been a total net reduction of 215,000 shares, and in the last 20 trading days, the cumulative net reduction reached 2.876 million shares [1] - As of now, southbound funds hold 112 million shares of HeartCare Medical-B, which accounts for 4.63% of the company's total issued ordinary shares [1] Company Overview - HeartCare Medical Technology Co., Ltd. specializes in providing comprehensive medical solutions for treating structural heart diseases [2] - The company's main business involves the research and commercialization of transcatheter and surgical solutions in the field of structural heart disease [2] - The product pipeline includes transcatheter aortic valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) products, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products, and surgical support products, with operations in both domestic and international markets [2]
心通医疗-B（02160.HK）：9月18日南向资金减持7.7万股